Inflammation and right ventricle: the hunting of the missing link.

[1]  R. Kronmal,et al.  Relationship of CRP, IL-6, and fibrinogen with right ventricular structure and function: the MESA-Right Ventricle Study. , 2013, International journal of cardiology.

[2]  L. Lind,et al.  Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women , 2013, Journal of Human Hypertension.

[3]  O. Vittos,et al.  Biomarkers and their involvement in the early diagnosis of right ventricular dysfunction in type 2 Diabetes Mellitus , 2012, Journal of medicine and life.

[4]  C. Stefanadis,et al.  Fibrinogen and cardiovascular disease: genetics and biomarkers. , 2011, Blood reviews.

[5]  C. Stefanadis,et al.  C-reactive protein and endothelial dysfunction: gazing at the coronaries. , 2011, International journal of cardiology.

[6]  C. Kaymaz,et al.  Enhanced hemostatic indices in patients with pulmonary arterial hypertension: an observational study. , 2010, Thrombosis research.

[7]  R. Frank,et al.  C-Reactive Protein in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy and Relationship with Ventricular Tachycardia , 2010, Cardiology Research and Practice.

[8]  C. Stefanadis,et al.  Inflammatory biomarkers predicting events in atherosclerosis. , 2010, Current medicinal chemistry.

[9]  B. Housset,et al.  Role for interleukin-6 in COPD-related pulmonary hypertension. , 2009, Chest.

[10]  D. Panagiotakos,et al.  Comparative Value of Simple Inflammatory Markers in the Prediction of Left Ventricular Systolic Dysfunction in Postacute Coronary Syndrome Patients , 2009, Mediators of inflammation.

[11]  T. Nawrot,et al.  C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. , 2009, Journal of the American College of Cardiology.

[12]  R. Cortes,et al.  Inflammatory activation and left ventricular mass in essential hypertension. , 2008, American journal of hypertension.

[13]  R. Targoński,et al.  Relationship between inflammatory markers and clinical patterns of atrial fibrillation in patients with congestive heart failure. , 2008, Kardiologia polska.

[14]  E. Muxfeldt,et al.  Relation of Left Ventricular Hypertrophy With Systemic Inflammation and Endothelial Damage in Resistant Hypertension , 2007, Hypertension.

[15]  S. Sindel,et al.  An Association Between Inflammatory State and Left Ventricular Hypertrophy in Hemodialysis Patients , 2005, Renal failure.

[16]  B. Howard,et al.  Relation of left ventricular hypertrophy to inflammation and albuminuria in adults with type 2 diabetes: the strong heart study. , 2003, Diabetes care.

[17]  H. Scheld,et al.  The interleukin-6/interleukin-6-receptor system is activated in donor hearts. , 2002, Journal of the American College of Cardiology.

[18]  P. Gabriele,et al.  Activation of the cardiac interleukin‐6 system in advanced heart failure , 2001 .

[19]  H. Scheld,et al.  Activation of the cardiac interleukin-6 system in advanced heart failure. , 2001, European journal of heart failure.

[20]  M. Humbert,et al.  Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. , 1995, American journal of respiratory and critical care medicine.